Latest Healthcare Research Reports

Tag: cell and gene therapy contract development and manufacturing organization (cdmo) market report

  • 2024-2033 Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Forecast: Predicted Growth Rate and Market Size

    2024-2033 Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Forecast: Predicted Growth Rate and Market Size

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market from 2024 to 2033?
    The cell and gene therapy contract development and manufacturing organization (CDMO) market has experienced exponential growth, expected to rise from $4.24 billion in 2023 to $5.41 billion in 2024, with a CAGR of 27.7%. Factors contributing to this growth include technological advancements, favorable regulatory frameworks, increased investment, a high prevalence of genetic disorders, and a growing number of strategic partnerships.

    The cell and gene therapy CDMO market is expected to see exponential growth, reaching $14.52 billion by 2028 at a CAGR of 28.0%, driven by expanded therapeutic applications, regulatory evolution, increased investment, and global collaboration. Trends include personalized therapy demand, automation growth, expanded manufacturing capacities, novel delivery systems, and sustainability focus.

    Claim Your Free Sample of the Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15753&type=smp

    What Key Factors Are Fueling the Growth of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
    The increasing prevalence of cancer cases is expected to boost the cell and gene therapy CDMO market. This prevalence is driven by aging populations and lifestyle changes. CDMOs help develop targeted treatments, improving cancer patient outcomes. According to Macmillan Cancer Support, the number of cancer patients in the UK is projected to rise from 3 million in 2022 to 5.3 million by 2040. Thus, the increasing cancer prevalence is propelling the growth of the CDMO market.

    What Are the Major Segments of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
    1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy
    2) By Phase: Phase 1, Phase 2, Phase 3, Phase 4
    3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications

    What New Trends Are Transforming the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
    Companies in the cell and gene therapy CDMO market are expanding portfolios with advanced solutions like PluriMatrix technology for efficient cell-based product manufacturing. In January 2024, Pluri launched PluriCDMO, offering end-to-end cell therapy manufacturing services utilizing this technology.

    Order Now for Fast Delivery of Your Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report!
    https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-contract-development-and-manufacturing-organization-cdmo-global-market-report

    Which Regions Are Driving Growth in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
    North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cell and gene therapy contract development and manufacturing organization (cdmo) market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Include
    1. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Executive Summary
    2. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Segments
    3. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Size And Template Market Growth Rate
    4.  Key Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Trends
    5. Major Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market
    26. Top Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Companies
    27. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Opportunities And Strategies
    28. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Cell and Gene Therapy Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

    Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

    Cell Therapy Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    Learn More About The Business Research Company
    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/
    Americas +1 3156230293
    Asia +44 2071930708
    Europe +44 2071930708
    Email us at info@tbrc.info

    Follow us on:
    LinkedIn: https://in.linkedin.com/company/the-business-research-company
    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
    Found this article helpful? Share it on:

  • Understand How The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Is Poised To Grow Through 2024-2033

    Understand How The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Is Poised To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    The cell and gene therapy contract development and manufacturing organization (CDMO) market has witnessed exponential growth in recent years. This surge is driven by various factors, and its trajectory shows no signs of slowing down. Let’s explore the dynamics fueling this market.

    Market Growth Overview

    • 2023 Growth Stats: The market grew from $4.24 billion in 2023 to $5.41 billion in 2024, reflecting a compound annual growth rate (CAGR) of 27.7%.
    • Projected Growth: By 2028, the market is expected to reach $14.52 billion, with a CAGR of 28.0%.

    Key Drivers of Historic Growth

    • Technological Advancements: Rapid improvements in technology have accelerated the development and manufacturing processes.
    • Favorable Regulatory Frameworks: Governments and regulatory bodies have created environments conducive to innovation and growth.
    • Increased Investment: Significant capital infusion has supported research, development, and scaling of production.
    • High Prevalence of Genetic Disorders: The rise in genetic disorders has necessitated the development of targeted therapies.
    • Strategic Partnerships: Collaborations between companies have enhanced capabilities and expanded market reach.

    View More On The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-contract-development-and-manufacturing-organization-cdmo-global-market-report

    Future Growth Catalysts

    • Expanded Therapeutic Applications: Broader applications for cell and gene therapies are driving demand.
    • Regulatory Evolution: Ongoing regulatory changes are expected to further support innovation and market expansion.
    • Increased Investment: Continued financial backing will propel research and development.
    • Technological Innovations: New technologies will continue to improve efficiency and scalability.
    • Global Collaboration: Partnerships across borders are fostering knowledge sharing and resource pooling.

    Major Trends Shaping the Future

    • Personalized Therapies: Growing demand for therapies tailored to individual patients.
    • Automation and Digitalization: The rise of automated processes and digital tools to enhance production efficiency.
    • Manufacturing Capacity Expansion: Companies are increasing their production capabilities to meet rising demand.
    • Novel Delivery Systems: Development of new methods to deliver therapies more effectively.
    • Sustainability Focus: Heightened emphasis on reducing the environmental impact of manufacturing processes.

    Rising Cancer Rates Fuel Market Expansion

    • Cancer Prevalence: The growing number of cancer cases globally is a significant driver of the CDMO market.
      • Factors include aging populations, lifestyle changes, environmental exposures, and improved detection.
    • Role of CDMOs: These organizations are crucial in developing and manufacturing innovative treatments that target cancer more effectively.
      • Example: In the UK, cancer cases are projected to rise from 3 million in 2022 to 5.3 million by 2040, emphasizing the need for advanced therapies.

    Innovations in Cell and Gene Therapy Manufacturing

    • PluriMatrix Technology: Companies like Pluri are introducing advanced technologies to improve manufacturing processes.
      • Key Features: 3D cell expansion, high yield, consistent quality, automation, and control.
      • PluriCDMO: Launched in January 2024, this division offers end-to-end cell therapy manufacturing services, leveraging PluriMatrix technology.

    Strategic Acquisitions and Expansions

    • Ajinomoto’s Acquisition of Forge Biologics:
      • Details: In November 2023, Ajinomoto Co. Inc. acquired Forge Biologics for $620 million.
      • Impact: This acquisition strengthens Ajinomoto’s global capabilities in gene therapy manufacturing, particularly in adeno-associated virus (AAV) and plasmid gene therapy.

    Regional Insights and Market Segmentation

    • Leading Regions:
      • North America: The largest region in the market in 2023.
      • Asia-Pacific: Expected to be the fastest-growing region during the forecast period.
    • Market Segmentation:
      • By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy.
      • By Phase: Phase 1, Phase 2, Phase 3, Phase 4.
      • By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications.

    Conclusion
    The cell and gene therapy CDMO market is on a trajectory of rapid growth, driven by technological advancements, increased investment, and the rising demand for personalized therapies. As the market continues to evolve, it will play a crucial role in addressing global health challenges, particularly in the fight against cancer. With continued innovation and strategic expansions, the future looks promising for this dynamic and transformative industry.

    Request A Sample Of The Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15753&type=smp